Nuclear factors that mediate intrathymic signals are developmentally regulated by unknown
Nuclear Factors that Mediate Intrathymic  Signals Are 
Developmentally Regulated 
By Jyoti Sen*S Yoichi Shinkai,~S Frederick W.  Alt,~$  Ranjan  Sen, ll 
and Steven J.  Burakoff*S 
From  *Dana-Farber Cancer Institute, *Howard Hughes Medical Institute, Children's Hospital, 
and SHarvard Medical School, Boston, Massachusetts 02115; and IIRosenstiel Basic Medical 
Sciences Research Center, Brandeis Unitersity,  Waltham, Massachusetts 02254 
Summary 
Thymocytes  mature through several stages of development, defined by cell surface markers such 
as CD3, CD4, and CD8, in response to environmental cues. Signal transduction resulting from 
lymphocyte-stromal cell interactions is likely to activate inducible transcription  factors which 
in turn govern stage-specific gene expression. In this report we show that inducible transcription 
factors such as AP-1 and NF-AT are constitutively nuclear, in response to intrathymic signals, 
in freshly isolated thymocytes at all stages of maturation, In CD4+CD8 + double positive (DP), 
but  not  in  the more immature CD4-CD8-  double  negative  (DN)  thymocytes,  constant 
stimulus from the thymic environment is required to maintain nuclear AP-1. Thus, disruption 
of the thymus and incubation of thymocytes at 37~  downregulates DNA binding by nuclear 
factors  AP-1  and  NF-AT.  Similar  treatment of thymocytes has  previously  been  shown  to 
downregulate CD3  ~" chain phosphorylation and increase T  cell receptor CD3 expression on 
DP thymocytes,  which is a feature of repertoire selection. Since mature T cells maintain inducible 
nuclear factors in an inactive form until an encounter with antigen, we propose that downregulation 
of nuclear DNA binding proteins may reflect another feature of this stage of T cell maturation. 
T  ceU differentiation in the thymus proceeds via a series 
of discrete intermediates  that have been characterized 
largely on the basis of expression of cell surface molecules 
such  as  CD4,  CDS,  and the TCR-CD3  complex (1-3). 
During T cell development the most immature thymocytes 
lack all of these markers and are referred to as double nega- 
tive  ([DN] 1 CD4-CDS-)  cells.  T  cell development  is 
blocked at the DN stage in mice deficient in either recombi- 
nation activation genes, RAG 1 or RAG 2, the TCR B chain 
(for a review see reference 4), or in mice carrying the SCID 
mutation (5). Mice deficient in the lymphocyte-specific pro- 
tein tyrosine kinase p56 lc~, or expressing a dominant nega- 
tive mutant of p561r  also attenuate development at the DN 
stage, indicating a role for this enzyme at this  stage of T 
cell development.  DN thymocytes mature to cells that ex- 
press both CD4 and CD8 molecules, called double positive 
(DP) cells. Recent evidence suggests that transgenic expres- 
sion of a functionally rearranged TCR B chain gene in RAG- 
deficient mice (for a review see reference 4), or SCID mice 
(5) allows maturation of DN thymocytes to the DP stage. 
Cross-linking the TCR e chain on the surface of DN thymo- 
1 Abbreviations  used in thispaper:  DN, double negative; DP, double positive; 
EMSA, electrophoretic mobility shift assay; RAG, recombination activation 
gene;  SP, single positive. 
cytes  in fetal thymic organ cultures (FTOCs) (6), and in young 
adult RAG 1 or 2 deficient mice (7, 8), also mediates progres- 
sion to the DP stage of development.  However, expression 
of the o~ chain is required for subsequent maturation steps 
(4). DP cells expressing the ct/3 TCR are subject to positive 
selection, during which cells bearing TCRs that recognize 
self-MHC molecules are selected for further differentiation, 
as well as to negative selection, the process by which self- 
reactive T cells are eliminated (9). Selected thymocytes  finally 
mature to single positive (SP) cells expressing high levels of 
TCR,  and either CD4 or CDS. 
Transitions  between the different  stages of developing 
thymocytes are likely to be modulated by signals provided 
by the thymic environment, since intact thymus is crucial 
for the developmental process (10). Lymphocyte-stromal  cell 
interactions are known to phosphorylate  the TCR ~" chain 
(11) and activate the protein tyrosine kinase p56  lck (12). Cel- 
lular differentiation, resulting in expression of stage-specific 
genes, must be governed by the activation of inducible nu- 
clear DNA binding factors. Several  groups have studied DNA 
binding proteins in fetal (13, 14) and adult thymocytes (15-17). 
We have studied the expression of nuclear factors associated 
with mature T cell activation, during T cell maturation using 
RAG 2-/- mice as a source of thymocytes at the DN stage, 
and TCR 3 + RAG 2 -/-  or BALB/c mice as a source of 
thymocytes at the DP stage of development. Here we show 
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binding motifs are constitutively nuclear in response to in- 
trathymic signals;  (b), lymphocyte-stromal cell interactions 
are essential to maintain the activated nuclear phenotype in 
DP but not in DN thymocytes; and (c), DN but not DP 
thymocytes reinduce AP-1 in response to stimulation in vitro. 
These results indicate that activation of  inducible nuclear factors 
is exquisitely modulated during thymocytes maturation. 
Materials  and Methods 
Mice.  BALB/c  mice were bred and maintained at the Kedstone 
facility  of the Dana Farber Cancer Institute. RAG 2 -/- and TCK 
B  + RAG 2  -/- mice  were maintained in a pathogen-free environ- 
ment at the animal facility at Children's Hospital in Boston. 
In Vivo mAb Treatment of RAG 2 -/- Mice.  RAG 2 -/- mice 
were injected intraperitoneally with 300 #g of purified anti-CD3 
e mAb, 145-2Cll  (18), or anti-TCK /3  chain mAb  H57  (19). 
Thymuses were removed 6 d after injection for analysis. 
Preparan'on and Treatment  of Thymotytes.  Thymuses  from BALB/c, 
RAG 2 -/-, and TCR/$+ RAG 2 -/- were isolated, thymocytes 
were released into single cell suspension, filtered through a nylon 
mesh, and red blood cells were removed by lysis  with Tris/NH4C1 
solution at room temperature for 5 rain (20). Thymocytes in single 
cell suspension were either maintained on ice for the duration of 
the experiment, generally 3 h, or incubated at 37~  in a 5% CO2 
atmosphere with or without 10 ng/ml PMA and 20-200  nM 
ionomycin, at 4  x  106 cells/ml. SP thymocytes  from BALB/c  mice 
were purified, as described before (20), by incubation with anti- 
CD8 mAb (21), for 30 min on ice followed by rabbit complement 
(Cederlane Laboratories  Ltd., Homby, Ontario, Canada)-mediated 
lysis at 37~  for 45 rain,  for two rounds. 
Preparation of  Nuclear  Extracts  and Electrophoretic  Mobility Shift Anal- 
ysis.  Nuclear extracts were prepared by hypotonic lysis and ex- 
traction of nuclei with high salt buffer as described before (22). 
Protein concentrations were determined using the Bradford assay 
(Pierce, Rockford, IL) and equivalent amounts of extracts used for 
in vitro binding assays. Binding assays were carried out in a final 
volume of 10/~1 containing 6 mM Hepes, pH 7.9, 60 mM NaC1, 
and 6% glycerol  for 15 min using indicated probes. Anti-Fos-1  an- 
tibody was a gift from J. Jain (Dana Farber Cancer Institute) (23), 
anti-Fos-2 and anti-Jun antibodies  were purchased  from Santa Cruz 
Biotechnology (Santa Cruz, CA). Anti-cyclic  AMP response ele- 
ment binding protein (CREB) antibody was purchased from Up- 
state Biotechnology,  Inc. (Lake  Placid, NY). NF-AT  probe was de- 
rived from the murine I1r  promoter (16). AP-1 probe used was 
generated by annealing synthetic oligonucleotides containing the 
AP-1 site from the metaUothioenine  gene promoter (24). SRF-SP-1 
probe was derived from the IL-2ga promoter region (25). The 
probes were labeled with polynucleotide kinase and 3,-[32P]ATP. 
Binding reactions were analyzed by electrophoresis through 4% 
polyacrylamide gels in 0.SX Tris-borate buffer. 
Results 
Nuclear Factors AP-1 and NF-AT A re Constitutively Nuclear, 
and  in  DNA  Binding  Form in  Thymocytes  In  Viv~  Total 
BALB/c thymocytes and purified mature SP (CD4 + CDS-) 
thymocytes were cultured at 37~  in the presence or absence 
of PMA and ionomycin. Nuclear extracts prepared from such 
cells were analyzed by electrophoretic mobility shift assays 
(EMSA)  using probes  that bind NF-IcB and AP-1  nuclear 
factors.  3-h treatment with PMA and ionomycin at 37~ 
resulted in induction of AP-1 in the SP thymocytes (Fig.  1, 
lane 9), but not in the total thymocytes (Fig. 1, lane 5). NF- 
KB binding was observed  in both total thymocytes (Fig.  1, 
compare  lanes  2  and 3),  as  well  as  in  CD4 +  CDS-  SP 
thymocytes (Fig.  1, compare lanes 6 and 7). Binding assays 
were normalized to the amount of nuclear protein used in 
the assays,  and in most experiments, a probe containing binding 
sites for serum response  factor (SRF) and the transcription 
factor SP-1, derived from the human IL-2Ro~ gene promoter, 
was used as an additional normalization criterion. Proteins 
binding to this probe showed minimal variation between ex- 
tracts made from thymocytes incubated under various condi- 
tions. These observations are consistent with those of others 
(14-16), and indicate that total thymocytes  do not induce AP-1 
in response  to PMA and ionomycin. One interpretation of 
these studies is that the majority of thymocytes lack expres- 
sion of the proteins that bind the AP-1  motif. 
We found, however,  that nuclear extracts  prepared from 
freshly isolated thymocytes contained nuclear proteins that 
bound to the NF-AT and AP-1  DNA elements in EMSA. 
Both factors were also detected in nuclear extracts from thymo- 
cytes kept on ice for 3-6 h (Fig. 2 A, lanes 1 and 4), but were 
significantly diminished in extracts prepared from thymocytes 
incubated at 37~  for the same duration (Fig.  2 A, lanes 
2 and 5).  Furthermore, PMA and ionomycin treatment of 
thymocytes  did not induce the NF-AT or AP-1 binding factors 
found in freshly isolated thymocytes (Fig. 2 A, lanes 3 and 
6).  It is important to note that with the AP-1  probe two 
Figure  1.  PMA and ionomycin  treatment  does not induce  AP-1 in adult 
thymocytes.  Extracts  were prepared from total thymocytes  (lanes  2-5) or 
from purified  CD4 + CD8- thymocytes  (lanes 6-9) from BALB/c mice. 
EMSA was carried out using a probe for NF-KB (lanes I-3 and 6 and 7) 
or AP-1 (lanes 4 and 5 and 8 and 9). Nuclear  extracts were  derived  from 
thymocytes  incubated  at 37~  (lanes 2, 4, 6, and 8) or with PMA (10 
ng/ml) and ionomydn  (200 nM) (lanes 3, 5, 7, and 9). 
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ing to AP-1 and NF-AT  motifs  are 
constitutively nuclear in freshly 
isolated thymocytes. (A) EMSA 
was carried out using the NF-AT 
probe (lanes 1-3) and AP-1 probe 
(lanes 4-6). Extracts were from 
single cell suspension of thymo- 
cytes kept on ice for 3 h (lanes I 
and 4); incubated  at 37~  for 3 h 
(lanes 2 and 5); activated with 
PMA and ionomycin  at 37"C for 
3 h (lanes 3 and 6). (Arrow,  left) 
Position of the NF-AT complex; 
(arrow, right) the AP-1 complex. 
(B) EMSA was carried out using 
AP-1 probe and nuclear extracts 
from thyrnocytes  kept on ice. The 
binding reaction  contained no ex- 
tract, (lane 1), and no antibody, 
(lane 2); anti-Fos (lanes 3 and 4); 
anti-Jun (lane 5); and anti-CREB 
(lane 6) antibodies. 
new, faster migrating nucleoprotein complexes were seen in 
extracts from PMA- and ionomycin-induced thymocytes (Fig. 
2, lane 6).  These bands result from specific binding to the 
AP-1 probe and are distinct  from the band induced by the 
intrathymic interactions. Chen and Rothenberg (16) have pre- 
viously shown that  the AP-1/CRE  site from the  -161  to 
-143 region of the IL-2 5' flanking region bound proteins 
from the Fos, Jun, and CREB families in thymocyte extracts 
stimulated by PMA and ionomycin. To determine which pro- 
teins are induced by intrathymic  signals,  we included anti- 
bodies directed against Fos and Jun or the CREB family of 
proteins in the binding  reactions.  As seen in Fig. 2 B,  two 
anti-Fos  and one anti-Jun  antibody diminished  binding  to 
the AP-1 probe whereas anti-CREB antibody had no effect. 
Anti-CREB  antibody  generated  a  "supershifted"  band  in 
EMSA with thymocyte extract and a CRE probe (data not 
shown). Residual binding to the AP-1 probe in the presence 
of the anti-Fos and anti-Jun antibodies may result from pro- 
teins of the Fos and Jun family not recognized by the antisera 
or from the presence of other DNA binding  proteins  that 
may bind to the site in the absence of Fos and Jun proteins. 
We conclude that  inducible transcription  factors that  bind 
to AP-1 and NF-AT probes are constitutively nuclear in im- 
mature  thymocytes,  presumably  in  response  to  lympho- 
cyte-stromal cell interactions. Making single cell suspensions 
disrupts these signals resulting in the observed loss of DNA 
binding activity. Unlike mature SP thymocytes and T  cells, 
where PMA and ionomycin treatment  induces NF-AT and 
AP-1  binding  factors,  we  noted  that  stimulation  of total 
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thymocytes did not  reinduce  these nuclear  factors.  Panned 
DP thymocytes, lacking SP thymocytes and contaminating 
stromal cells also show the same DNA binding profile as total 
thymocytes (data not shown). These results suggest that in- 
tracellular activation pathways are operative in vivo, and are 
not mimicked by PMA and ionomycin or anti-CD3  E mAb 
(data  not  shown). 
Inactivation of AP-I  DNA  Binding Activity Is Developmen- 
tally Regulated: Analysis of DN Thymocytes from RAG 2- l- 
Mice.  In  mice deficient for either  RAG  1 or  2  gene,  the 
thymus  remains  small  and  populated  with  DN  cells.  In- 
troducing  a rearranged  TCR t3 chain  gene into  this back- 
ground results in a normal-sized thymus consisting mainly 
of DP cells (for a review see reference 4). These DP thymo- 
cytes express the/3 TCRs at the cell surface instead of c~/3 
TCRs expressed on the  surface of normal  DP thymocytes. 
/3 + RAG 2-/-  mice provide a population  of cells  arrested 
at an early DP stage of T  cell differentiation.  To investigate 
the expression and induction of AP-1 during DN to DP stage 
of differentiation of thymocytes, we examined nuclear extracts 
prepared from RAG 2-/-  and TCR fl § RAG 2-/-  thymo- 
cytes by EMSA. 
Nuclear extracts from DN thymocytes from RAG 2-/- 
mice contain AP-1 binding proteins (Fig. 3 A, lane 1). This 
binding  was not  significantly reduced in cells incubated at 
37~  (Fig.  3 A, lane 2). PMA and ionomycin treatment did 
not  increase  the  level  of  AP-1  DNA  binding  activity 
significantly (Fig. 3 A, lane 3). The SRF-SP-1 probe derived 
from the human  IL-2Rot gene promoter  showed the same level of  binding in extracts made from thymocytes  incubated 
under various conditions (Fig. 3 A, lanes 4-6). We conclude 
that inducible nuclear factors binding to AP-1 are constitu- 
tively nuclear in the most immature thymocytes. However, 
the mechanisms that inactivate DNA binding upon incuba- 
tion of thymocytes  in single cell suspension at 37~  are not 
present in these cells. 
DP Thymocytes Require the Thymic Environment to Maintain 
AP-I in DNA Binding Form in the Nucleus.  In contrast  to 
what was observed in RAG 2 -/-  DN  thymocytes,  AP-1 
binding activity present in DP thymocytes obtained from TCR 
~+ RAG 2 -/- mice, kept at 0~  (Fig. 3 B, lane 1) was sub- 
stantially decreased upon 37~  incubation (Fig. 3 B, lane 
2). This was similar to that observed with total adult thymo- 
cyte extracts as shown in Fig. 2, lanes 4 and 5. Furthermore, 
in several independently generated extracts from TCR ~ + 
RAG 2-/-  thymocytes, we observed little or no induction 
of the  AP-1  binding  activity  in  response  to  PMA  and 
ionomycin stimulation (Fig. 3 B, lane 3). The doublet of  faster 
migrating nudeoprotein complexes was seen  in extracts from 
PMA and ionomycin-treated DP thymocytes from TCR ~ + 
RAG 2-/-  mice as well.  As before,  the IL-2Rol-derived 
SRF-SP-1 probe served as an additional normalizing control 
(Fig. 3 B, lanes 4-6). We conclude, therefore, that the prop- 
erty of thymocytes to inactivate DNA binding to the AP-1 
probe, upon 37~  incubation, is developmentally regulated, 
coinciding with transition of  the thymocytes to the DP stage. 
Inactivation of DNA binding by NF-AT also appears to be 
similarly regulated (data not shown). During this transition, 
the cells also lose the ability to reinduce AP-1 or NF-AT by 
in vitro stimulation. 
DP Thymocytes Generated by Treatment of RAG 2-/- Mice 
with Anti-CD3 6 Antibody Exhibit Characteristics of an Inter- 
mediate Between DN and DP Thymocytes.  Anti-CD3 e mAb 
treatment of DN thymocytes from RAG 1- or 2-deficient 
mice induces differentiation of the DN cells to the DP stage 
(6-8). We injected anti-CD3 e mAb into young adult RAG 
2-/-  mice as described previously (8). Briefly, 300/~g of 
mAb was injected on day 1 into RAG 2-/-  mice and 6 d 
later, 100-300  x  106 largely DP cells were isolated (Fig. 4 
A). Thymocytes  from RAG 2 -/- mice did not express CD4 
or CD8 (Fig. 4 A, top). The majority of thymocytes from 
/3+  RAG 2-/-  mice expressed CD4 and CD8,  but there 
were no mature cells that expressed only CD4 or CD8 (Fig. 
4 A, middle). The majority of thymocytes from RAG 2-/- 
mice injected with anti-CD3 e mAb were DP whereas a few 
were DN (Fig. 4 A,  bottom) (7,  8). 
The nuclear properties of thymocytes generated by anti- 
CD3 ~ mAb treatment were assessed by EMSA analysis of 
nuclear extracts  from thymocytes isolated from anti-CD3 
mAb-treated mice. Thymocytes incubated on ice showed AP-1 
DNA binding activity (Fig. 4 B, lane 1). Incubation of  thymo- 
cytes at 37~  inactivated DNA binding by the AP-1 probe 
but not to the same extent as in the DP thymocytes from 
either normal mice or the RAG 2-/-  mice expressing the 
TCR/3 chain (Fig. 4 B, lane 2). PMA and ionomycin treat- 
ment of these cells reinduced the same AP-1 binding com- 
plex and the two new faster migrating bands (Fig. 4 B, lane 
3).  PMA and ionomycin treatment of DN thymocytes in- 
duced the slowest migrating band seen in freshly isolated 
thymocytes (Fig. 3 A, lane 3),  whereas stimulation of DP 
thymocytes from TCR B-expressing RAG 2-/-  mice and 
Figure 3.  DP,  but not DN  thymocytes require  the 
thymic microenvironment to maintain  AP-1 binding  pro- 
teins in the nucleus. (A) Nuclear extracts were prepared 
from  single cell suspension of thymocytes from  RAG 
2-/- mice. Thymocytes were kept on ice for 3 h (lanes 
I  and 4); at 37"C for 3 h (lanes 2 and 5); at 37~  for 
3 h in the presence of PMA (10 ng/ml) and ionomycin 
(200 nM), (lanes 3 and 6). (B) Nuclear extracts prepared 
from TCR ~ + RAG 2-/- mice. Thymocytes were kept 
on ice for 3 h (lanes I  and 4); at 37~  for 3 h (lanes 2 
and 5); at 370C for 3 h in the presence  of PMA (10 ng/ml) 
and ionomycin  (200 nM), (lanes 3 and 6). EMSA was car- 
ried out with specific probes as indicated above each set 
of lanes. 
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induced two faster moving bands (Fig.  3 B, lane 3).  Thus, 
the properties of anti-CD3 e mAb-induced DP cells are in- 
termediate between DN and DP thymocytes with  regards 
to inactivation  of DNA binding upon incubation at 37~ 
and similar to the DN cells in the ability to reinduce AP-1 
in vitro.  Since freshly isolated thymocytes from RAG 2-/- 
mice that have been or have not been treated with anti-CD3 
e mAb show DNA binding to the AP-1 probe, it is unlikely 
that the induction of AP-1 DNA binding activity is simply 
the result of cellular activation by CD3 e chain cross-linking. 
We, therefore, propose that these nuclear characteristics identify 
an "early DP" stage, that may be an intermediate in normal 
T  cell development. 
Discussion 
AP-1 and NF-AT DNA binding  activities were detected 
in nuclear extracts from freshly isolated thymocytes. These 
data suggest that interactions  between thymocytes and stromal 
cells result in signals that  activate nuclear factors AP-1 and 
NF-AT. These data are consistent with previously reported 
observations that intrathymic signals  result in TCR ~" chain 
phosphorylation, which is a phenotype of an activated T call, 
and also activate the protein tyrosine kinase p56  Ick. The cell 
surface molecules that  mediate  the intrathymic  signals  are 
largdy unknown,  however, a role for CD4 as been postu- 
lated in the modulation of TCR ~" chain phosphorylation and 
p561ok activation  (11, 12). 
Incubation of thymocyte single cell suspensions at 37~ 
resulted in the loss of DNA binding  activity by AP-1  and 
NF-AT. This suggests that  thymocyte-stromal cell interac- 
tions are required  to maintain  the nuclear factors in DNA 
binding form.  Inactivation  of DNA binding  takes place in 
the absence of protein synthesis (data not shown) but requires 
energy because cells incubated on ice retain DNA binding. 
The downreguhtion of nuclear factors is devdopmentally regu- 
lated, being most prominent in ~/B and cffB TCR expressing 
DP thymocytes, but not in immature DN thymocytes. These 
data correlate with the reported observation that incubation 
ofDP thymocytes in single cell suspension results in dephos- 
phorylation of the TCR ~'chain  and upregulation of cell sur- 
face expression of the TCR-CD3  complex. 
The  nuclear characteristics  of DP calls  induced by anti- 
CD3 e mAb treatment  of RAG 2-/-  mice share features of 
both DN and DP thymocytes. IntrathymicaUy induced AP-1 
was significantly downregulated upon incubation of the cells 
at 37~  although not to the same extent as in DP thymo- 
cytes from normal  or RAG 2-/-  TCR ~  transgenic  mice. 
However, AP-1 DNA binding activity was strongly induced 
upon PMA and ionomycin treatment,  as has been seen only 
Figure 4.  Anti-CD3 e mAb treatment of RAG 2-/-  mice leads to 
the generation of immature DP thymocytes.  (A) Thymocytes  from RAG 
2-/- mice  (top), B  + RAG 2-/- mice  (middle),  and RAG 2-/- mice in- 
jected with anti-CD3 e mAb (bottom),  were stained with FITC-labeled 
anti-CD8 and PE-labded  anti-CD4 mAbs. (B) Nuclear extracts were  pre- 
pared from thymocytes  generated  by in vivo  injection of anti-CD3 e mAb 
in RAG 2-/- mice, thymocytes  were maintained on ice (lanes 1 and 4); 
incubated at 37~  (lanes 2 and 5); or incubated at 37~  with PMA (10 
ng/ml) and ionomycin (200 nM) (lanes 3 and 6). EMSA was carried out 
with the specific probes indicated above  each set of lanes. 
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typic analysis of thymocytes from anti-CD3 e mAb-injected 
mice showed a majority of DP cells and only a small number 
of DN cells. These data can be interpreted to indicate that 
the majority of cells in the DP population generated by anti- 
CD3 E mAb treatment are at an intermediate stage during 
DN to DP transition.  If this is the case, it is possible that 
the difference  between the DP cells generated by cross-linking 
CD3 e and by transgenic expression of the TCR fl chain, 
reflect additional signals  transmitted via the fl TCR-gp33 
complex (26) and associated surface molecules. Alternatively, 
it cannot be ruled out that all the cells did not receive the 
signals upon cross-linking the CD3 e chain equally and the 
data reflect a mixed population of cells at various stages of 
differentiation. 
The analysis of inducible factors presented in this study, 
and previously published data regarding phosphorylation of 
the CD3  g" chain or activation of pSO  ok, could be a result 
of signals received by thymocytes that maintain these cells 
through their differentiation programs, or a result of death 
signals received by unselected thymocytes. We favor the first 
interpretation because these factors are constitutively nuclear 
in the earliest DN stage of development, at which stage it 
is unlikely that the cells have been signaled to die.  Mature 
T cells maintain inducible nuclear factors in an inhibited often 
cytosolic form until activated by an encounter with antigen. 
Upon antigen-mediated stimulation, inducible nuclear factors 
are activated to translocate to the nucleus and bind DNA 
(27). We speculate that these proteins are activated in imma- 
ture thymocytes in response to developmental signals during 
the DN and DP stages and are downregulated before transi- 
tion to the mature SP stage. 
As mentioned before, several groups have studied the in- 
duction of inducible nuclear factors in thymocytes at different 
stages of development (14-16). In all of these papers, the ques- 
tion addressed was that of nuclear factors induced upon stim- 
ulation of purified thymocytes, at various stages of matura- 
tion, and correlated with the capacity of thymocytes to produce 
IL-2. The results suggested that whereas immature DN and 
mature SP thymocytes produced IL-2 and activated AP-1 and 
NF-AT, DP thymocytes did not respond similarly. The in- 
terpretation was that the lack of NF-AT and AP-1 in DP 
thymocytes reflected their inability to make IL-2. The impli- 
cation that thymocytes at the DP stage are incapable of ex- 
pressing and activating NF-AT and AP-1 is misleading. This 
conclusion has been changed by our observation that DP 
thymocytes do express NF-AT and AP-1, presumably in re- 
sponse to intrathymic signals. The fact that DP thymocytes 
do not make significant amounts of IL-2 in vivo (28), in spite 
of activated NF-AT and AP-1 complexes, suggests that these 
factors may be necessary, but are not sufficient for transcrip- 
tion of the IL-2 gene. 
In conclusion, the ability of thymocytes at different stages 
of development to modulate DNA binding nuclear factors 
is exquisitely regulated. Immature thymocytes at DN and 
DP stages of development activate AP-1 and NF-AT in re- 
sponse to intrathymic signals. Disruption of the intrathymic 
signals leads to inactivation of DNA binding by AP-1 and 
NF-AT in DP thymocytes but not in DN thymocytes. Fur- 
thermore, immature DN thymocytes activate AP-1 upon stim- 
ulation in vitro but DP thymocytes do not, even though the 
proteins involved in these interactions are expressed in these 
cells. Incubation of thymocyte single cell suspension at 37~ 
has been previously shown to decrease tyrosine phosphoryla- 
tion of TCR ~" chain and increase cell surface expression of 
the TCR-CD3 complex. Because SP thymocytes express high 
levels of TCR-CD3,  the increased CD3 expression on DP 
thymocytes upon 37~  incubation has been postulated to 
mimic part of the maturation response. Since mature T cells 
maintain nuclear factors in an inhibited form, to be activated 
upon encountering antigen, we speculate that the mechanisms 
resulting in the inactivation of transcription factors may also 
be a part of the maturation step that ultimately produces SP 
cells. As a consequence, SP cells that emerge would not con- 
tain DNA binding AP-1 or NF-AT in the nucleus, until res- 
timulated by antigen during an immune response. 
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